AAV capsid design: A Goldilocks challenge
- PMID: 35093287
- DOI: 10.1016/j.molmed.2022.01.003
AAV capsid design: A Goldilocks challenge
Abstract
In vivo therapeutic gene transfer has emerged as a novel class of medicines. Its feasibility relies on the safe and efficacious delivery of genetic cargo to the appropriate targets. The adeno-associated virus (AAV) vector manifested itself as a preferred gene delivery vehicle enabling therapeutic gene expression for several clinical indications. Here, we cover the recent trends in AAV capsid engineering to enhance its targeting specificity, safety, and endurance. While each and every desirable trait can be individually remodeled, combining several attributes in one capsid amounts to a significant engineering challenge. Taking advantage of virion structure and phylogenetics, harnessing directed evolution, sequence analyses, and machine learning, researchers develop novel capsid variants to realize the goals of safe and enduring gene therapy.
Keywords: adeno-associated virus vector; directed evolution; gene therapy; machine learning.
Copyright © 2022 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of interests The authors have no interests to declare.
Similar articles
-
Boosters for adeno-associated virus (AAV) vector (r)evolution.Cytotherapy. 2023 Mar;25(3):254-260. doi: 10.1016/j.jcyt.2022.07.005. Epub 2022 Aug 20. Cytotherapy. 2023. PMID: 35999132
-
Machine-learning-guided Directed Evolution for AAV Capsid Engineering.Curr Pharm Des. 2024;30(11):811-824. doi: 10.2174/0113816128286593240226060318. Curr Pharm Des. 2024. PMID: 38445704 Review.
-
Systematic multi-trait AAV capsid engineering for efficient gene delivery.Nat Commun. 2024 Aug 4;15(1):6602. doi: 10.1038/s41467-024-50555-y. Nat Commun. 2024. PMID: 39097583 Free PMC article.
-
Genetic Engineering of AAV Capsid Gene for Gene Therapy Application.Curr Gene Ther. 2020;20(5):321-332. doi: 10.2174/1566523220666200930105521. Curr Gene Ther. 2020. PMID: 32998676 Review.
-
Chemical Modifications of the Capsid for Redirecting and Improving the Efficacy of Adeno-Associated Virus Vectors.Hum Gene Ther. 2021 Dec;32(23-24):1433-1438. doi: 10.1089/hum.2021.124. Epub 2021 Aug 17. Hum Gene Ther. 2021. PMID: 34254844 Free PMC article.
Cited by
-
Human cell surface-AAV interactomes identify LRP6 as blood-brain barrier transcytosis receptor and immune cytokine IL3 as AAV9 binder.Nat Commun. 2024 Sep 8;15(1):7853. doi: 10.1038/s41467-024-52149-0. Nat Commun. 2024. PMID: 39245720 Free PMC article.
-
The Expression and Function of the Small Nonstructural Proteins of Adeno-Associated Viruses (AAVs).Viruses. 2024 Jul 29;16(8):1215. doi: 10.3390/v16081215. Viruses. 2024. PMID: 39205189 Free PMC article. Review.
-
Probing recombinant AAV capsid integrity and genome release after thermal stress by mass photometry.Mol Ther Methods Clin Dev. 2024 Jun 24;32(3):101293. doi: 10.1016/j.omtm.2024.101293. eCollection 2024 Sep 12. Mol Ther Methods Clin Dev. 2024. PMID: 39100914 Free PMC article.
-
Strategies to improve safety profile of AAV vectors.Front Mol Med. 2022 Nov 1;2:1054069. doi: 10.3389/fmmed.2022.1054069. eCollection 2022. Front Mol Med. 2022. PMID: 39086961 Free PMC article. Review.
-
Chemical approaches to probe and engineer AAV vectors.Nanoscale. 2024 Jul 25;16(29):13820-13833. doi: 10.1039/d4nr01300j. Nanoscale. 2024. PMID: 38978480 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources